Atlas Trials

The Effect of Terlipressin in the Prevention of Type 2 Hepatorenal Syndrome by Improving Mean Arterial Pressure

Clinical trial NCT02489864 · UNKNOWN

Trial details

NCT number
NCT02489864
Sponsor
Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatorenal Syndrome
Start date
2015-07-01
Primary completion
2017-07-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.